1. Introduction {#s0005}
===============

Clear cell adenocarcinoma of the cervix (CCAC) is rare. The etiology and pathogenesis of the tumors are, presently, unclear. It may occur either in young women, associated with diethylstilbestrol (DES) exposure in utero from maternal use, or older women. The tumor may arise in both the ectocervix (typically, associated with DES) or the endocervix. We report on a case of CCAC in an adolescent without prior, maternal DES exposure.

2. Case report {#s0010}
==============

A 19-year-old woman, without coexisting disease, reported post-coital bleeding and vaginal discharge for approximately 1 month. She has reported to be monogamous and she had first experienced sexual intercourse was at the age of 15. She had neither family history of cancer nor DES exposure. A 3-centimeter polypoid mass at her cervix was detected during a pelvic examination. A cervical biopsy and a conventional PAP smear were obtained. The cytological specimen was negative for intraepithelial lesions or malignancy (NILM). The histopathological specimen had shown cervical tissue involved with malignant infiltration consisting of large round cells with clear cytoplasm and glandular formation. These findings were suggestive of a clear cell carcinoma tumor. She was referred to the gynecological oncology unit of our hospital in March 2016. We were unable to locate a cervical mass. However, a small ulcer at upper lip of cervix was discovered. On pelvic and rectal examinations, both parametriums were smooth. The high-risk human papilloma virus (hrHPV) test resulted positive for human papilloma virus (HPV) type 51. A colposcopy was performed and revealed a transformation zone type 1 with an ulcerative lesion positioned at 10--2 o\'clock with coarse punctuation and a mosaic pattern at the 5 o\'clock position. A loop electrosurgical excision procedure (LEEP) was performed and the histopathological typing was consistent with a clear cell carcinoma ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}). Nonetheless, the endocervical margins were not free. All parameters from blood chemistry analysis were within normal ranges. Chest X-ray and Anti-HIV antibody tests were negative. The patient was diagnosed with CCAC; stage Ib1, in accordance to the International Federation of Obstetricians and Gynecologists (FIGO) classification. She was then admitted as an inpatient on May 2016. A radical abdominal hysterectomy, bilateral pelvic lymphadenectomy, bilateral salpingectomy and an incidental appendectomy were performed. During the operation, there was a small accumulation of serous fluid in the pelvic cavity. No sign of extra-uterine spread of neoplastic disease was observed. The postoperative period was without complications and unremarkable. The final specimen had revealed no residual clear cell tumor. Cervical intraepithelial neoplasia 3 (CIN3) was observed in all quadrants. Free vaginal resection margins from the CIN3 in all quadrants were shown. Both sides of the parametrium were unremarkable. No evidence of metastatic carcinoma in any lymph nodes was indicated. After the surgery, the plan was to undergo follow-up without adjuvant treatment. Up to the time of writing this case report and it has been 6 months post operatively, she remains free of disease.Fig. 1Tumor cells are composed of a tubulocystic pattern of cells with abundant clear cytoplasm and large irregular nuclei. (Hematoxyline and eosin staining, original magnification 40 ×.)Fig. 1Fig. 2Microscopically, the tumor cells invade endocervical tissue without definite lymphatic invasion. (Hematoxyline and eosin staining, original magnification 10 ×.)Fig. 2

3. Discussion {#s0015}
=============

In the post-DES era, the prevalence of CCAC was found to be approximately 4--9% of the cases of adenocarcinoma of the cervix ([@bb0005]). There are clearly separated peaks of incidence in young and advanced aged women who have been exposed to DES in utero. The first peak occurs in women who are 17 to 37 years of age (mean age, 26 years), while the second peak arises in women who are 44 to 88 years of age (mean age, 71 years) ([@bb0010]). In contrast, Thomas et al., and Seki et al., suggest that the mean ages of non-DES exposed women was at 53 and 50.8 years old, respectively ([@bb0015], [@bb0020]). The etiology and pathogenesis of CCAC remain unclear. Risk factors of CCAC are not associated with risk factors of squamous cell carcinoma (SCC). These factors include; advanced age, epidemiological risk, multiple sexual partners, smoking, socioeconomic status, contraceptive use and infection by human papillomavirus (HPV) ([@bb0015], [@bb0025]). HPV DNA was not detected in any of the non-mucinous adenocarcinomas including clear cell, serous, and mesonephric carcinomas ([@bb0025]). Only a few studies have explored the association between hrHPV and CCAC. Most of the HPV-positive CCAC cases have been confirmed with HPV 18 and 31 DNA sequences ([@bb0030]). In this study, the hrHPV test result was positive for type 51 which has a high oncogenic potential. It may be either a cofactor in the development of CCAC or a coincidental finding. Therefore, more data is needed to confirm the association between HPV infection and CCAC. One study has found that maternal DES exposure, incident of a previous maternal miscarriage, birth during the autumn months, and premature births are risk factors for CCAC in young women ([@bb0035]). As in clear cell ovarian cancer, there have been case reports that have suggested an association between CCAC and cervical endometriosis, however, the evidence is far from being confirmed ([@bb0040]).

The microscopic patterns of CCAC are arranged as; solid, tubulocystic, papillary patterns or a combination of features ([@bb0045]). The tumor in a solid pattern displays sheets of cells containing abundant glycogen-rich clear cytoplasm, an atypical nuclei, and mitoses. The tubulocystic pattern contains tubules and cystic spaces outlined by oxyphilic, hobnail, or clear cells. The papillary pattern is the least common variant and often coexists with the solid or tubulocystic areas. The most favorable outcome is associated with the tubulocystic pattern, followed by papillary and solid patterns, respectively^.^([@bb0045]). The patient in this study presented with vaginal bleeding, which is the most common initial symptom. In young patients, the condition is often misdiagnosed as dysfunctional uterine bleeding or a vaginal tumor ([@bb0015]). During the pelvic examination, 81% of the cervix appeared to be abnormal ([@bb0010]). It was found that 80% of the cervix was involved with endophytic growth with a high possibility of deep cervical infiltration ([@bb0005]). Cytology has been found to be less efficient in diagnosing cervical adenocarcinomas ([@bb0010], [@bb0015]). Thomas and colleagues reported that only 6 of 31 CCAC patients (18%) had an abnormal Pap test ([@bb0015]). Cytology was of no benefit in the diagnosis in this case.

Patients with CCAC were reported to have a worse 5-year survival rate (67%) than those with SCC (80%) and non-clear cell carcinomas (77%) but without statistical significance ([@bb0015]). A study had previously reported that the prognosis of patients with early-stage CCAC was not inferior to other types of cervical adenocarcinomas ([@bb0010]). In comparison with SCC of the cervix, CCAC has a higher risk of lymph node metastasis and more frequently extends to the uterine corpus and parametrium ([@bb0005], [@bb0015]). The clear cell histology, by itself, does not appear to portend a poor prognosis. Most CCAC patients were diagnosed in the early stages (I/II) ([@bb0010], [@bb0045]). The overall survival rate of patients with stages I/II of CCAC is excellent (81.5--91%) ([@bb0010], [@bb0015]).

Surgery is the definitive treatment of CCAC in the early stages ([@bb0015], [@bb0020]). Important negative prognostic factors are; a tumor size more than 4 cm, a presence of positive lymph node metastasis, and carcinoma in advanced stages ([@bb0005], [@bb0010], [@bb0015]). These factors are similar to what has been found in patients with SCC. Additionally, when considering the pathological findings, the unfavorable prognosis is also associated with a presence of nuclear atypia, a high mitotic activity, and a solid or mixed growth pattern. The most common extra-pelvic sites of recurrence are the lungs, liver, and skeletal system ([@bb0005]). Adjuvant radiotherapy appears to be effective in the local control and should be administered using similar indications as is used in the high-risk, early stage SCC ([@bb0015]). The median time for tumor recurrence in stages I and II, CCAC, was at 12 months ([@bb0005], [@bb0015]). Vaginal recurrence commonly occurred at 3.5 to 4 years ([@bb0015]).

In conclusion, this case study exhibits a CCAC arising in a young adult who presented with vaginal bleeding. Differential diagnosis of carcinoma of cervix and vagina should be considered even without a history of exposure to DES. According to the literature review, tumor cells in this case, were arranged in a tubulocystic pattern and there was no residual disease in the pathology in the specimen obtained from the radical hysterectomy. This is indicative of a favorable prognosis. We also reviewed the literature of CCAC in the young women without DES exposure from the period of 2000--2016 ([Table 1](#t0005){ref-type="table"}). Nearly all of the cases occurred in women of Asian descent and it may be one epidemiological risk of CCAC in the young women. New cases of CCAC of cervix continue to occur although there has been no exposure to DES. Moreover, most of the cases were diagnosed in the early stages and had a favorable prognosis. In selected young patients who present with favorable prognostic factors such as a small tumor size and is well differentiated, a fertility-preserving treatment appears to be safe and should be considered as a viable option. However, in one case, the patient developed extra pelvic metastasis to the lungs and brain despite having received adjuvant chemotherapy. This may be explained by the negative prognostic factors obtained from the microscopic findings. In the surveillance program; pelvic examination, cytology, and imaging techniques (CXR, IVP and CT) should be considered.Table 1Reported cases of clear cell carcinoma in young women without DES exposure; literature search during 2000--2016 period.Table 1Age (years old)FIGO stageTumor size (cm)TreatmentFollow-up period (months)Outcome[@bb0020]18Ib26NAC (mitomycin etoposide carboplatin) RH, BPLND48Free of disease[@bb0055]19Ib2 with pelvic node metastasis8Conization, BPLND, BOT Adjuvant RT24Free of disease[@bb0060]6Ib12Partial trachelectomy12Free of disease[@bb0065]17Ib11.5RH, BPLND24Free of disease[@bb0035])16Ib13RH, BPLND, adjuvant CT (carboplatin, paclitaxel)24Free of disease14Ib26TAH BSO BPLND24Free of disease[@bb0070])15IIA pelvic LN metastasis7RH BPND BOT adjuvant CT (carboplatin, paclitaxel)6Free of disease[@bb0075]18 pregnant 33 weekIb10.6Cesarean section at 34 weeks then RH BPND BSO36Free of disease[@bb0050])10Ib2unknown (pelvic mass 14 cm)RH, BPLND adjuvant CT (carboplatin + paclitaxel)3Recurrent in lung and brain[^1]
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[^1]: DES, diethylstilbestrol; TAH, total abdominal hysterectomy; RH, radical hysterectomy; BSO, bilateral salpingoophorectomy; BPLND, bilateral pelvic node dissection; BOT; bilateral ovarian transposition; NAC, neoadjuvant chemotherapy; CT, chemotherapy; RT, radiotherapy.
